MeiraGTx Netherlands B.V.
Amsterdam
About MeiraGTx Netherlands B.V.
MeiraGTx Netherlands develops localized gene therapy using viral vector technology, with a particular emphasis on adeno-associated virus (AAV)-based treatments. The company supports the discovery and development of multiple therapeutic candidates, collaborating with scientific partners to advance their research. As part of a broader global group, it contributes to innovations in viral vector development and precision gene regulation platforms.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Nov 2005)
- Website: meiragtx.com
- Phone: +31.20.566.26.48
Industries & Categories
Biopharma, Biotechnology
Canonical: https://fsome.com/organization/meiragtx-netherlands-b-v-2988513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.